20527 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#302Compositions including triciribine and taxanes and methods of use thereof
#3034′-substituted nucleoside reverse transcriptase inhibitors
#304Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#305Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers
#306Nucleoside phosphoramidate prodrugs
#3077-deazapurine nucleosides for therapeutic uses
#308Methods for treating cancers using oral formulations of cytidine analogs
#309TREATMENT OF PROSTATE CANCER AND HEMATOLOGIC NEOPLASMS
#310LOCAL TREATMENT OF NEUROFIBROMAS
#311Solid forms of an antiviral compound
#312Compositions including triciribine and methods of use thereof
#313Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
#314Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
#315Antiviral compounds
#316NUCLEOSIDE SUPPLEMENTATION TO PROMOTE CELLULAR FUNCTION, GENETIC STABILITY AND REGENERATIVE APPLICATIONS
#317Substituted nucleosides, nucleotides and analogs thereof
#318Compositions containing resveratrol and nucleotides
#319Anti-viral pyrimidine nucleoside derivatives
#320Therapeutic applications of calcium electroporation to effectively induce tumor necrosis
#321Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD
#322REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#323Methods and compositions for inhibition of polymerase
#324Pan-selectin inhibitor with enhanced pharmacokinetic activity
#325Methods and compositions for the treatment of proliferative disorders
#326Combination therapy for the treatment of cancer
#327Compositions and methods for treating retinal degradation
#328LRRK-2-Mediated Neuronal Toxicity
#3292′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#330Composition for preventing or treating degenerative brain diseases including compound downregulating expression of BACE1 proteins
#331MODULATORS OF TOUSLED KINASE IN CELLULAR PROCESSES
#332Methods for potentiating immune response for the treatment of infectious diseases and cancer
#333Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
#334Uridine nucleoside derivatives, compositions and methods of use
#335COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES
#336Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#337Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment
#338Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#339Antiviral compounds
#340Compositions including triciribine and taxanes and methods of use thereof
#341Effective treatment of tumors and cancer with triciribine and related compounds
#342Drug formulations
#343Compositions including triciribine and trastuzumab and methods of use thereof
#344COMBINATION TREATMENT COMPRISING A HDAC6 INHIBITOR AND AN AKT INHIBITOR
#345Improving recognition
#346Compounds and pharmaceutical compositions for the treatment of viral infections
#347USE OF PYRIDONE DERIVATIVES IN THE PREVENTION OR TREATMENT OF TISSUE OR ORGAN TOXICITY INDUCED BY CYTOTOXIC AGENTS AND RADIATION
#3485′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#3492′,4′-substituted nucleosides as antiviral agents
#350Compositions and methods for treating cancer
#3512′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#352Inhibition of nonsense mediated mRNA decay by drugs that prevent hypusination of eukaryotic initiation factor 5A
#353Nucleoside phosphoramidate prodrugs
#354Methods for treating glaucoma using uridine diphosphate derivatives
#355Ticagrelor co-crystal
#356FRUIT EXTRACTS
#3572′-chloro nucleoside analogs for HCV infection
#358Dosing methods for treating disease
#359Methods and compositions for the treatment of proliferative disorders
#360Pharmaceutical combinations for treatment of specific cancers
#361Ribosome structure and protein synthesis inhibitors
#362Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#363Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
#364Methods and Compositions for Inhibition of Polymerase
#365Macrocyclic nucleoside phosphoramidate derivatives
#366METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE INFECTIONS
#367Methods and compositions for treating flaviviruses and pestiviruses
#368Antiviral compounds
#369Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
#370Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
#371Modulator of activity of adenylate cyclase
#3723,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#373Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors
#374Cancer methods
#375Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
#3762′-fluoronucleosides
#377Compositions containing resveratrol and nucleotides
#378Methods for treating cancers using oral formulations of cytidine analogs
#379Compositions including triciribine and taxanes and methods of use thereof
#380Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
#381Compositions including triciribine and methods of use thereof
#382Compositions including triciribine and trastuzumab and methods of use thereof
#383HEPATITIS C THERAPIES
#384Compositions including triciribine and one or more platinum compounds and methods of use thereof
#385Nucleoside phosphoramidate prodrugs
#386Combination therapy with antibody-drug conjugates
#387Local treatment of neurofibromas
#388Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases
#389Compounds and pharmaceutical compositions for the treatment of viral infections
#3902′,4′-substituted nucleosides as antiviral agents
#391Implantable device for controlled dissolution and diffusion of low solubility drug
#392Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#393Methods and Compositions for the Treatment of "Burning Feet Syndrome"
#3942′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
#395Substituted purine and 7-deazapurine compounds
#396COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
#3973,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
#398Pharmaceutical combinations for treatment of specific cancers
#399Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#400Compounds and methods for treatment of sickle cell or complications associated therewith
#401NUCLEOSIDE DERIVATIVES AS INHIBITORS OF VIRAL POLYMERASES
#402Complex and method for enhancing nuclear delivery
#403Compounds and pharmaceutical compositions for the treatment of viral infections
#4043,5-disubstituted and 3,5,7-trisubstituted-3-oxazolo and 3-thiazolo[4,5-]pyrimidin-2-one compounds and prodrugs thereof
#405Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
#406Nucleoside phosphoramidate prodrugs
#407COMPOSITIONS INCLUDING TRICIRIBINE AND METHODS OF USE THEREOF
#408FRUIT EXTRACTS
#409DOSING METHODS FOR TREATING DISEASE
#410Small molecule immunopotentiators and assays for their detection
#411USE OF COMPOUNDS ACTIVATING SIRT-3 FOR MIMICKING EXERCISE
#412COMPOSITIONS INCLUDING TRICIRIBINE AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR COMPOUNDS OR SALTS THEREOF AND METHODS OF USE THEREOF
#413Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#414Ribosome Structure and Protein Synthesis Inhibitors
#415MARKER OF PROSTATE CANCER
#416Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
#417COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL DYSFUNCTION ASSOCIATED WITH SIRS OR SEPSIS
#418HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#419SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS
#420Anti-viral pyrimidine nucleoside derivatives
#421Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation
#422Combination therapy with antibody-drug conjugates
#423Ribosome structure and protein synthesis inhibitors
#424COMPOSITIONS INCLUDING TRICIRIBINE AND ONE OR MORE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF
#4252-fluoronucleosides
#426TARGETED GENE DISRUPTIONS IN THE IQGAP2 GENE
#427Antiviral Agents
#428Hepatitis C therapies
#429QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE
#430Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#431COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT
#432PRODRUGS OF TRICIRIBINE AND TRICIRIBINE PHOSPHATE
#433COMPOSITIONS INCLUDING TRICIRIBINE AND TRASTUZUMAB AND METHODS OF USE THEREOF
#434Nucleoside phosphoramidate prodrugs
#435COMPOSITIONS INCLUDING TRICIRIBINE AND BORTEZOMIB AND DERIVATIVES THEREOF AND METHODS OF USE THEREOF
#436COMPOSITIONS INCLUDING TRICIRIBINE AND TAXANES AND METHODS OF USE THEREOF
#4372',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS
#438Receptor-type kinase modulators and methods of use
#439Treatment of cancers of the blood using selected glycomimetic compounds
#440Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
#441METHODS OF TREATING VIRAL INFECTIONS WITH ANTHRACYCLINE ANTIBIOTICS
#442METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH
#443Pan-selectin inhibitor with enhanced pharmacokinetic activity
#444EFFECTIVE TREATMENT OF OVARIAN CANCER USING TRICIRIBINE AND RELATED COMPOUNDS
#445Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
#446Compositions and methods of use of compounds to increase cancer patient survival time
#447METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION
#448Preventing diseases in infants delivered via caesarean section
#449Compounds and pharmaceutical compositions for the treatment of viral infections
#450Method for Stimulating the Intestinal Flora
#451Local treatment of neurofibromas
#452Compounds and methods for treatment of sickle cell disease or complications associated therewith
#453Method and Means for Enhanced Pulmonary Drug Delivery
#4542′-fluoronucleosides
#455Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
#456Compounds and pharmaceutical compositions for the treatment of viral infections
#457Compounds and pharmaceutical compositions for the treatment of liver disorders
#458Composition having antitumor effect
#459USE OF ACETYLATED OR ESTERIFICATED AZACYTIDINE, DECITABINE, OR OTHER NUCLEOSIDE ANALOGS AS ORAL AGENTS FOR THE TREATMENT OF TUMORS OR OTHER DYSPLASTIC SYNDROMES SENSITIVE TO HYPOMETHYLATING AGENTS
#460Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiation
#461Compositions and methods for treating or preventing imflammatory diseases
#462Compositions and methods for treating or preventing inflammatory diseases
#463Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
#464Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
#465Cholesterol efflux and uses thereof
#466Composition for promoting collagen production
#467Methods and compositions for treating flaviviruses and pestiviruses
#468Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#469Effective treatment of tumors and cancer with triciribine and related compounds
#470Hepatitis C therapies
#471Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#472Methods and compositions for treating flaviviruses and pestiviruses
#4733,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#474MODULATORS OF RIBOSOMAL FUNCTION AND IDENTIFICATION THEREOF
#475β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
#476Receptor-type kinase modulators and methods of use
#477Combination therapies for cancer and proliferative angiopathies
#478Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
#479Ribosome structure and protein synthesis inhibitors
#480Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#481Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof
#482Compositions and methods for treating or preventing inflammatory diseases
#483Methods of inhibiting orthopoxvirus replication with nucleoside compounds
#484Aryl phosphate derivatives of D4T with potent anti-viral activity
#485Crystalline drug form
#486Coumarin derivative
#487Method of identifying molecules that bind to the large ribosomal subunit
#488Pharmaceutical combinations for the treatment of cancer
#489Compositions and methods for prevention and treatment of coronavirus and related disorders
#490Oral formulations of CD73 compounds